Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Leica Biosystems e KUB Technologies, Inc. annunciano un nuovo accordo di distribuzione
  • USA - English
  • USA - Français
  • USA - español
  • USA - Deutsch
  • USA - Polski

Leica_Biosystems_Logo

News provided by

Leica Biosystems

Dec 13, 2017, 08:00 ET

Share this article

Share toX

Share this article

Share toX

CINCINNATI, 13 dicembre 2017 /PRNewswire/ -- Leica Biosystems e KUB Technologies, Inc. sono liete di annunciare un nuovo accordo di distribuzione mondiale per i sistemi di imaging di campioni. Questo accordo include i sistemi radiografici per campioni XPERT® di Kubtec per i centri anti-tumore al seno, il MOZART System® per l'imaging intra-operatorio per campioni del seno e la serie XPERT® 80 per i laboratori di patologia.

Kubtec_Logo
Kubtec_Logo

Le suite di soluzioni di imaging di Kubtec sono vendute a radiologi, chirurghi, medici e patologi del seno in tutto il mondo. I sistemi radiografici per campioni al punto di cura XPERT di Kubtec consentono di ottenere esiti migliori, forniscono un maggiore comfort per il paziente grazie a tempi più brevi per la procedura e consentono inoltre di avere risultati estetici migliori. Il MOZART System, l'unico sistema di imaging intra-operatorio per campioni del seno che utilizza la tecnologia della tomosintesi 3D aiuta ad aumentare al massimo la conservazione del seno pur rimuovendo l'intero tumore. La serie XPERT 80 migliora l'efficienza dei laboratori di patologia con sistemi di imaging pratici e dedicati che forniscono la massima risoluzione.

"La nostra strategia è fornire la migliore tecnologia di categoria, che aumenta la precisione nell'individuazione del tumore al seno pur migliorando anche l'esperienza dei pazienti", ha affermato Alain de Lambilly, Presidente di Leica Biosystems Tissue Acquisition Solutions. "Gli innovativi sistemi di Kubtec per l'imaging dei campioni per i centri anti-tumore al seno, le sale operatorie e i laboratori di patologia sono la scelta ottimale per il nostro portafoglio di prodotti in continua crescita e si allineano con la mission della nostra azienda di progredire nella diagnostica oncologica e migliorare la vita delle persone".

L'accordo include la distribuzione esclusiva del nuovo sistema di imaging dei campioni a marchio condiviso Mammotome Confirm sia negli Stati Uniti che in tutto il mondo, oltre alla distribuzione non esclusiva delle serie XPERT 40, XPERT 80 e MOZART System negli Stati Uniti, in Canada e in diversi paesi in Europa e Asia. KUBTEC continuerà a commercializzare tali prodotti con l'etichetta KUBTEC attraverso i suoi canali di distribuzione.

"Il nostro obiettivo in KUBTEC è fornire ai medici gli strumenti necessari ad offrire i migliori esiti oncologici e cosmetici per i loro pazienti pur garantendo vantaggi economici per i loro istituti", ha affermato Vikram Butani, amministratore delegato di Kubtec. "Abbiamo stabilito forti relazioni con gli OEM nell'ultimo decennio e siamo estremamente lieti di poter aggiungere Leica Biosystems al nostro elenco di partner OEM. Questo accordo aumenta ulteriormente il nostro accesso ai professionisti sanitari specializzati nella biopsia, chirurgia e patologia del tumore al seno negli Stati Uniti e in tutto il mondo".  

Informazioni su Leica Biosystems
Leica Biosystems è leader mondiale nelle soluzioni e nell'automazione del flusso di lavoro, integrando ogni fase del workflow, dalla biopsia alla diagnosi. In quanto unica azienda con un workflow dalla biopsia alla diagnosi, vantiamo una posizione esclusiva che ci consente di eliminare le barriere tra ciascuna di queste fasi.  La nostra mission di "Progredire nella diagnostica oncologica e migliorare la vita delle persone" è al centro della nostra cultura aziendale.  I nostri prodotti facili da usare e sempre affidabili migliorano l'efficienza del flusso di lavoro e la sicurezza diagnostica. L'azienda è presente in più di 100 Paesi e ha sede in Germania, a Nussloch.

Per ulteriori informazioni, è possibile visitare il sito Web mammotome.com o LeicaBiosystems.com.

Informazioni su Kubtec
Kubtec, un marchio registrato di KUB Technologies, Inc., offre gli strumenti più innovativi fra le apparecchiature a raggi X digitali per la radiografia dei campioni, l'imaging a basso dosaggio, la ricerca scientifica, l'analisi forense, i test non distruttivi, l'irradiazione e molto altro. Kubtec è certificata ISO 9001 e ISO 13485 ed è conforme ai requisiti di Stati Uniti, Canada ed Europa in quanto a sicurezza delle radiazioni. I sistemi e l'assistenza con formazione del produttore sono disponibili in tutto il mondo. 

Per ulteriori informazioni, visitare kubtec.com.

LEICA e il logo Leica sono marchi registrati di Leica Microsystems IR GmbH. Mammotome è un marchio registrato di Devicor Medical Products, Inc., parte di Leica Biosystems, negli Stati Uniti e opzionalmente in altri paesi. Confirm è un marchio di Devicor Medical Products, Inc., parte di Leica Biosystems, negli Stati Uniti e opzionalmente in altri paesi.

Contatto per i media:  Courtney Hill, Global Brand Marketing Specialist
Telefono: 847-405-7041
[email protected]

Logo - https://mma.prnewswire.com/media/396793/Leica_Biosystems_Logo.jpg
Logo - https://mma.prnewswire.com/media/618961/Kubtec_Logo.jpg

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Leica Biosystems Expands Leading Digital Pathology Portfolio for the US with Multiple Launches at Pathology Visions 2025

Leica Biosystems Expands Leading Digital Pathology Portfolio for the US with Multiple Launches at Pathology Visions 2025

In a groundbreaking showcase of innovation designed to accelerate the digital transformation of pathology, Leica Biosystems proudly launches its...

Leica Biosystems Unveils Next-Gen Pathology Portfolio at ECDP 2025

Leica Biosystems Unveils Next-Gen Pathology Portfolio at ECDP 2025

In a significant stride toward transforming the future of cancer diagnostics and research, Leica Biosystems proudly showcases its latest digital...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Medical Pharmaceuticals

Medical Pharmaceuticals

Medical Equipment

Medical Equipment

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.